Why These Are Hot: Agios Pharmaceuticals (NASDAQ:AGIO), ZIOPHARM Oncology (NASDAQ:ZIOP), Oplink Communications (NASDAQ:OPLK), Materion Corporation (NYSE:MTRN), TASER International (NASDAQ:TASR)


Agios Pharmaceuticals (NASDAQ:AGIO) major shareholder Celgene European Investment Co bought 228,645 shares of the company’s stock in a transaction that occurred on Tuesday, December 16th. The stock was purchased at an average price of $110.75 per share, for a total transaction of $25,322,433.75. Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) in last trading activity decreased -0.08% to close at $119.62. Company weekly performance is 0.05% while its quarterly performance stands at 152.63%. Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) is -3.83% away from its 52 week high.

Ziopharm Oncology, Inc. (NASDAQ:ZIOP) and Intrexon Corporation (NYSE: XON) announced on 3 December the presentation of clinical and preclinical studies from their immuno-oncology programs at the American Association for Cancer Research (AACR) 2014 Immunology and Immunotherapy Meeting. On last trading day ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) moved up 12.41% to close at $4.80. Its volatility for the week is 8.44% while volatility for the month is 7.57%. ZIOP’s EPS growth for past 5 years was 11.10%. ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) monthly performance is 31.87%.

On 2 December the fairness of the proposed acquisition of Oplink Communications, Inc. (NASDAQ:OPLK) by Koch Optics Inc. (“Koch”) is the subject of an examination by WeissLaw LLP, a national class action, shareholder rights law firm. On last trading day Oplink Communications, Inc. (NASDAQ:OPLK) remains unchanged to close at $24.26. Its volatility for the week is 0.41% while volatility for the month is 0.25%. OPLK’s sales growth for past 5 years was 7.30% and its EPS growth for past 5 years was 38.30%. Oplink Communications, Inc. (NASDAQ:OPLK) monthly performance is 0.33%.

Materion Corporation (NYSE:MTRN0 on 9 December has announced that Senior Vice President, Finance and Chief Financial Officer John D. Grampa plans to retire before the end of the year, wrapping up 17 years of service with the company. Materion’s Board of Directors has appointed Joseph P. Kelley to succeed him as vice president, finance and chief financial officer, effective Jan. 1. Materion Corporation (NYSE:MTRN) has 1.20% insider ownership while its institutional ownership stands at 91.80%. In last trading activity company’s stock closed at $33.99.

TASER International (NASDAQ:TASR) CMO Luke Larson sold 2,350 shares of the company’s stock on the open market in a transaction dated Wednesday, December 17th. The stock was sold at an average price of $24.53, for a total transaction of $57,645.50. Following the completion of the transaction, the chief marketing officer now directly owns 36,316 shares of the company’s stock, valued at approximately $890,831. On Friday shares of TASER International Inc. (NASDAQ:TASR) closed at $23.98. Company’s sales growth for last 5 years was 8.20% and EPS growth for next 5 years is recorded as 30.00%.


Leave a Reply

Your email address will not be published. Required fields are marked *